The purpose of this study is to evaluate the efficacy of an online platform that allows neurologists and therapists to exchange therapy recommendations, communicate assessments and plan physical therapy, occupational therapy as well as speech and swallowing therapy for their patients.
The aim of this study is to enroll 185 patients in the intervention group and 185 patients in the control group. Patients in the intervention group come from the same region (Münsterland), the control group will consist of patients outside this region. The patients in the intervention group undergo therapies planned and coordinated through the online platform for 12 months. The patients in the intervention group will be evaluated using the PDQ-39, UPDRS, H\&Y as well as Schwab \& England. The patients in the control group will be evaluated using the PDQ-39.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
370
Coordination of the treatment through the online platform "JamesAKTIV" that allows neurologists and therapists to select specialised therapies for the predominant symptoms of the patients and communicate easily about problems during the treatment
Universitätsklinikum Münster, Klinik für Neurologie
Münster, North Rhine-Westphalia, Germany
RECRUITINGChange in Quality of Life measured by PDQ 39
The Parkinson's Disease Questionnaire (PDQ-39, max. score of 100 indicates the worst quality of life)
Time frame: Change from Baseline PDQ 39 at 12 months
Change in Health-related resource use in the elderly population, assessed by FIMA
FIMA stands for "Questionnaire concerning Health-related resource use in the elderly population" and is a German questionnaire assessing the Health-related resource use in the elderly population
Time frame: Change from Baseline FIMA at 12 months
Change in disease severity measured by UPDRS
UPDRS - Unified Parkinson's Disease Rating Scale, max. score of 199 points indicates the worst outcome
Time frame: Change from Baseline UPDRS at 12 months
Change in disease severity measured by Hoehn & Yahr
Hoehn \& Yahr is a simple scale that describes disease severity on a scale of 0-5, with 5 indicating severe disability
Time frame: Change from Baseline UPDRS at 12 months
Change in mobility, measured by Schwab- & England-Scale
Schwab- \& England-Scale assesses the capabilities of people with impaired mobility. The scale uses percentages with 100% indicating full independence.
Time frame: Change from Baseline Schwab-&England-Scale at 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.